Search Results
PARP inhibitors as first-line maintenance therapy in ovarian cancer
Maximizing the potential of PARP inhibitors as first-line maintenance therapy in ovarian cancer
Maintenance Therapy in Ovarian Cancer: PARP Inhibitors
PARP inhibitors in ovarian cancer: Clinical updates from SGO 2023
Personalizing Advanced Ovarian Cancer Treatment With PARP Inhibitors and Novel Approaches
Should 1L maintenance with PARP inhibitors be given to all patients with ovarian cancer?
Long-term benefit from 1L maintenance PARP inhibitors in ovarian cancer
The potential of PARP inhibitors in ovarian cancer: PAOLA-1, PRIMA & VELIA
Dr. Berek Discusses the Impact of PARP Inhibitors on Ovarian Cancer
PARP Maintenance Therapy in Recurrent Ovarian Cancer
Gynecologic Cancer Education: PARP Inhibitor Therapy
Maintenance Therapy: PARP Inhibitor or Bevacizumab
